Abstract
Background and Aims: ADAPTABLE is the first PCOR trial in US, comparing the effectiveness of two aspirin doses for secondary prevention of atherosclerotic disease. Novel features include patients’ representation as research partners, leveraging of electronic health records, participation via internet and low cost. Direct patient engagement can improve research impact and provide access to minority populations, often less represented in clinical research. We aim to analyze patient's data from Montefiore Hospital in Bronx, NY, serving a community of socioeconomically disadvantaged minorities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
